Literature DB >> 8944257

Exposure to Cryptococcus neoformans var. gattii--a seroepidemiological study.

R A Seaton1, A J Hamilton, R J Hay, D A Warrell.   

Abstract

An enzyme-linked immunosorbent assay was developed to study prevalence of immunoglobulin G (IgG) antibody to non-capsular Cryptococcus neoformans var. gattii antigen in a population of healthy Papua New Guinea (PNG) controls and patients. Patients with acute C. neoformans var. gattii meningitis had elevated levels of IgG which declined significantly following treatment (P = 0.034). Levels in the sera of convalescent patients were significantly higher than those in PNG controls (P < 0.001), which in turn were significantly higher than in a UK control group (P < 0.001). Clear differences were observed amongst the PNG controls. Adults had significantly higher levels than children (P = 0.002) and men had significantly higher levels than women (P = 0.047). No difference was observed between levels in patient-related and unrelated controls. IgG responses in PNG controls mirror the prevalence of disease in this population. It is postulated that exposure to C. neoformans var. gattii is less common in children and women due to some as yet unidentified behavioural difference and that exposure occurs away from the home environment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8944257     DOI: 10.1016/s0035-9203(96)90297-7

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  5 in total

Review 1.  Cryptococcus gattii: a resurgent fungal pathogen.

Authors:  Vishnu Chaturvedi; Sudha Chaturvedi
Journal:  Trends Microbiol       Date:  2011-08-29       Impact factor: 17.079

Review 2.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 3.  Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals.

Authors:  Edmond J Byrnes; Karen H Bartlett; John R Perfect; Joseph Heitman
Journal:  Microbes Infect       Date:  2011-06-01       Impact factor: 2.700

4.  Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.

Authors:  Tomomi Saijo; Jianghan Chen; Sharon C-A Chen; Lindsey B Rosen; Jin Yi; Tania C Sorrell; John E Bennett; Steven M Holland; Sarah K Browne; Kyung J Kwon-Chung
Journal:  MBio       Date:  2014-03-18       Impact factor: 7.867

Review 5.  Cryptococcal meningitis: epidemiology and therapeutic options.

Authors:  Derek J Sloan; Victoria Parris
Journal:  Clin Epidemiol       Date:  2014-05-13       Impact factor: 4.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.